Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Equity Average (2022 - 2025)

Historic Equity Average for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $35.0 million.

  • PAVmed's Equity Average changed N/A to $35.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year change of. This contributed to the annual value of -$15.5 million for FY2024, which is 13732.04% down from last year.
  • PAVmed's Equity Average amounted to $35.0 million in Q3 2025.
  • Over the past 5 years, PAVmed's Equity Average peaked at $53.1 million during Q2 2022, and registered a low of -$37.4 million during Q3 2023.
  • Moreover, its 4-year median value for Equity Average was -$1.8 million (2024), whereas its average is $3.9 million.
  • As far as peak fluctuations go, PAVmed's Equity Average crashed by 30090.8% in 2024, and later surged by 31042.92% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Equity Average stood at $19.7 million in 2022, then tumbled by 270.36% to -$33.6 million in 2023, then skyrocketed by 103.16% to $1.1 million in 2024, then surged by 3198.02% to $35.0 million in 2025.
  • Its last three reported values are $35.0 million in Q3 2025, $41.3 million for Q2 2025, and $19.0 million during Q1 2025.